LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

A reliable and accessible approach using a simple blood draw to detect hepatocellular carcinoma in cirrhotic patients has been validated in a clinical trial with promising results. More...
14 Jun 2024
Image: The Hairpin Duplex Enhanced Fidelity Sequencing (HiDEF-seq) could reveal the causes of mutations (Photo courtesy of Shutterstock)

New Technique Reveals Earliest Signs of Genetic Mutations

A new study has introduced a groundbreaking technique that can accurately identify early molecular changes in the DNA code that precede mutations. More...
14 Jun 2024
Image: The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test runs on the cobas liat system (Photo courtesy of Roche)

Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes

A new diagnostic test employs sensitive PCR technology and requires just a single nasal swab sample to quickly and accurately identify and differentiate among four major respiratory viruses, guiding appropriate treatment decisions. More...
13 Jun 2024
Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)

First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening

A cost-effectiveness analysis has revealed that using biparametric MRI as an initial screening tool is less cost-effective than the traditional approach of first-line PSA testing followed by multiparametric MRI. More...
12 Jun 2024
Image: The Olink Explore platform can identify proteins in blood that may provide a 7-year warning for various cancers (Photo courtesy of Olink Holding)

Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis

Researchers have employed a cutting-edge proteomics platform to identify blood proteins that could potentially provide a seven-year advance warning for various types of cancer. More...
11 Jun 2024
Image: Illustration representing DELFI approach for lung cancer detection (Photo courtesy of Cancer Discovery)

AI Technology-Based Blood Test Identifies Lung Cancer Earlier

Researchers have leveraged AI to spot patterns of DNA fragments linked to lung cancer, which has led to the development and validation of a liquid biopsy that could identify the disease earlier. More...
10 Jun 2024
Image: The ultra-sensitive blood test detects tiny amounts of cancer DNA left in the body after treatment for early breast cancer (Photo courtesy of ICR)

Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse

A new type of blood test can predict breast cancer recurrence in high-risk patients who have undergone surgery or other treatments months or even years before relapse occurs. More...
07 Jun 2024
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Steam Sterilizer
Hi Vac II Line
New
Electrolyte Analyzer
CBS-4000 (CBS-400)


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
INTEGRA BIOSCIENCES AG